Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sight Sciences, Inc.

2.76
+0.10003.76%
Post-market: 2.800.0400+1.45%16:15 EDT
Volume:118.43K
Turnover:319.77K
Market Cap:141.68M
PE:-2.69
High:2.78
Open:2.61
Low:2.51
Close:2.66
Loading ...

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

GlobeNewswire
·
7 hours ago

The Market Meltdown Is No Match for Our Quant System’s 5 Latest Picks

InvestorPlace
·
14 Apr

Needham Sticks to Its Hold Rating for Sight Sciences (SGHT)

TIPRANKS
·
09 Apr

Sight Sciences, Inc. (NASDAQ:SGHT) Looks Inexpensive But Perhaps Not Attractive Enough

Simply Wall St.
·
30 Mar

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

GlobeNewswire
·
26 Mar

Sight Sciences’ Earnings Call: Cautious Optimism Amid Challenges

TIPRANKS
·
07 Mar

Q4 2024 Sight Sciences Inc Earnings Call

Thomson Reuters StreetEvents
·
07 Mar

Sight Sciences Is Maintained at Neutral by Piper Sandler

Dow Jones
·
06 Mar

Sight Sciences price target lowered to $2.50 from $3 at Lake Street

TIPRANKS
·
06 Mar

Sight Sciences price target lowered to $4 from $5 at Stifel

TIPRANKS
·
06 Mar

Sight Sciences: Hold Rating Amid Revenue Challenges and Reimbursement Progress

TIPRANKS
·
06 Mar

Sight Sciences price target lowered to $3.50 from $5.50 at Piper Sandler

TIPRANKS
·
06 Mar

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Envista Holdings (NVST) and Sight Sciences (SGHT)

TIPRANKS
·
06 Mar

Sight Sciences Faces Headwinds in Glaucoma and Dry Eye Markets, Hold Rating Maintained

TIPRANKS
·
06 Mar

Sight Sciences Inc (SGHT) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Challenges

GuruFocus.com
·
06 Mar

Sight Sciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Mar

Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics

Zacks
·
06 Mar

Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
06 Mar

Sight Sciences sees FY25 revenue $70M-$75M, consensus $78.07M

TIPRANKS
·
06 Mar

Sight Sciences Reports 2024 Financial Results and 2025 Outlook

TIPRANKS
·
06 Mar